Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Gabriella Uhercsák"'
Autor:
Attila Paszt, Zsolt Simonka, Krisztina Budai, Zoltan Horvath, Marton Erdos, Marton Vas, Aurel Ottlakan, Tibor Nyari, Zoltan Szepes, Gabriella Uhercsak, Aniko Maraz, Laszlo Torday, Laszlo Tiszlavicz, Judit Olah, Gyorgy Lazar
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
IntroductionTherapeutic treatment for advanced-stage (T2–T4) gastroesophageal junction (GEJ) and gastric cancer involves neoadjuvant chemotherapy with subsequent surgical intervention.MethodNeoadjuvant oncological treatment for GEJ and gastric canc
Externí odkaz:
https://doaj.org/article/3a74c0c67f4b470b8a89f7f85107b42c
Autor:
Anikó Maráz, Adrienn Cserháti, Gabriella Uhercsák, Éva Szilágyi, Zoltán Varga, János Révész, Renáta Kószó, Linda Varga, Zsuzsanna Kahán
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In patients with metastatic renal cell cancer, based on limited evidence, increased sunitinib exposure is associated with better outcome. The survival and toxicity data of patients receiving individualized dose escalated sunitinib
Externí odkaz:
https://doaj.org/article/db5ea6401a0a4868bae9430a4b6c2c44
Autor:
Katalin Priskin, Sára Pólya, Lajos Pintér, Gábor Jaksa, Bernadett Csányi, Márton Zsolt Enyedi, Eszter Sági-Zsigmond, Farkas Sükösd, Orsolya Oláh-Németh, Gyöngyi Kelemen, Alíz Nikolényi, Gabriella Uhercsák, Dóra Sántha, Ágnes Dobi, Éva Szilágyi, Erzsébet Valicsek, László Tordai, Rozália Tóth, Zsuzsanna Kahán, Lajos Haracska
Publikováno v:
Cancers, Vol 13, Iss 14, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor; however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, covera
Externí odkaz:
https://doaj.org/article/22ec5a79d67449369ff0378bcb87d5e9
Autor:
Márton Zsolt Enyedi, Orsolya Oláh-Németh, Bernadett Csányi, Farkas Sükösd, Alíz Nikolényi, Gyöngyi Kelemen, Zsuzsanna Kahán, László Tordai, Lajos Haracska, Sára Pólya, Ágnes Dobi, Éva Szilágyi, Dóra Sántha, Eszter Sági-Zsigmond, Erzsébet Valicsek, Katalin Priskin, Rozália Tóth, Gábor Jaksa, Lajos Pintér, Gabriella Uhercsák
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
Autor:
Gabriella Uhercsák, Ágnes Dobi, Adrienne Cserháti, Alíz Nikolényi, Melinda Csenki, Orsolya Rusz, Renáta Kószó, Erzsébet Valicsek, Zsuzsanna Kahán
Publikováno v:
OncoTargets and therapy. 11
Orsolya Rusz, Renáta Kószó, Ágnes Dobi, Melinda Csenki, Erzsébet Valicsek, Alíz Nikolényi, Gabriella Uhercsák, Adrienne Cserháti, Zsuzsanna Kahán Department of Oncotherapy, University of Szeged, Szeged, Hungary Abstract: Fulvestrant is a pu
Autor:
János Révész, Anikó Maráz, Zsuzsanna Kahán, Éva Szilágyi, Zoltán Varga, Gabriella Uhercsák, Adrienn Cserháti, Linda Varga, Renáta Kószó
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Background In patients with metastatic renal cell cancer, based on limited evidence, increased sunitinib exposure is associated with better outcome. The survival and toxicity data of patients receiving individualized dose escalated sunitinib therapy
Autor:
András Vörös, Zsolt Simonka, Gabriella Uhercsák, Katalin Ormándi, Alíz Nikolényi, Zoltán Varga, Orsolya Rusz, Zsuzsanna Kahán, Gyöngyi Kelemen
Publikováno v:
Pathology & Oncology Research. 21:977-984
The evaluation of the effects of 1-year endocrine therapy (NET) was aimed at. A retrospective analysis of 42 cases with 46 stage II-III invasive, hormone receptor-positive, HER2-negative breast cancers was performed. One-year NET was planned with let
Autor:
Petra Hartmann, Dénes Garab, Dóra Bodnár, Péter Járomi, Gabriella Uhercsák, Andrea Szabó, Mihály Boros
Publikováno v:
Magyar Sebészet. 65:184-190
AbsztraktBevezetés:Átmeneti ischaemia kapcsán az ischaemia/reperfusiós (IR) károsodás elsődleges célpontja az erek endotheliuma, míg interstitialis cystitisben és haemorrhagiás cystitisben a gyulladás az epithelium/urothelium felől indul
Autor:
Ervin Tánczos, Sándor Hamar, Zsuzsanna Kahán, Maria Wagnerova, Erika Csörgő, Gabriella Uhercsák, Thomas Brodowicz, Alíz Nikolényi, Melinda Csenki, László Thurzó
Publikováno v:
Pathology & Oncology Research. 18:61-68
There is a need for the selection of those breast cancers where benefit may be attained from the addition of an anthracycline to the adjuvant chemotherapy. The expression of topoisomerase II alpha (TOP2A) protein in 3 cohorts of breast cancers treate
Publikováno v:
Orvosi Hetilap. 150:65-71
Neoadjuvant (preoperative) systemic therapy is a good possibility for the treatment of symptomatic breast cancers of the locoregional stage. Chemotherapy or hormone therapy chosen according to the characteristics of the primary tumor, result in the r